These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5118684)

  • 1. Clinical trials of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) given intravenously in the treatment of malignant melanoma in Uganda.
    Vogel CL; Comis R; Ziegler JL; Kiryabwire JW
    Cancer Chemother Rep; 1971 Apr; 55(2):143-9. PubMed ID: 5118684
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of malignant tumors other than melanoma.
    Kingra GS; Comis R; Olson KB; Horton J
    Cancer Chemother Rep; 1971 Jun; 55(3):281-3. PubMed ID: 5115849
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).
    Luce JK; Thurman WG; Isaacs BL; Talley RW
    Cancer Chemother Rep; 1970 Apr; 54(2):119-24. PubMed ID: 4334086
    [No Abstract]   [Full Text] [Related]  

  • 4. 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.
    Carter SK; Friedman MA
    Eur J Cancer (1965); 1972 Feb; 8(1):85-92. PubMed ID: 4552317
    [No Abstract]   [Full Text] [Related]  

  • 5. Intermittent treatment of metastatic malignant melanoma with high-dose 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
    Cowan DH; Bergsagel DE
    Cancer Chemother Rep; 1971 Apr; 55(2):175-81. PubMed ID: 5118686
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with disseminated melanoma.
    Gerner RE; Moore GE
    Cancer Chemother Rep; 1973 Feb; 57(1):83-4. PubMed ID: 4704107
    [No Abstract]   [Full Text] [Related]  

  • 7. Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer.
    Stolinsky DC; Bogdon DL; Solomon J; Bateman JR
    Cancer; 1972 Sep; 30(3):654-9. PubMed ID: 5075351
    [No Abstract]   [Full Text] [Related]  

  • 8. [Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma].
    Beretta G; Bajetta E; Bonadonna G; Tancini G; Orefice S; Veronesi U
    Tumori; 1973; 59(3):239-48. PubMed ID: 4729646
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.
    Moertel CG; Reitemeier RJ; Hahn RG; Schutt AJ
    Cancer Chemother Rep; 1970 Dec; 54(6):471-3. PubMed ID: 4946016
    [No Abstract]   [Full Text] [Related]  

  • 10. Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma.
    Einhorn LH; McBride CM; Luce JK; Caoili E; Gottlieb JA
    Cancer; 1973 Oct; 32(4):749-55. PubMed ID: 4751911
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary clinical trial and the physiologic disposition of 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide in man.
    Skibba JL; Ramirez G; Beal DD; Bryan GT
    Cancer Res; 1969 Nov; 29(11):1944-51. PubMed ID: 5358212
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.
    Falkson G; Van der Merwe AM; Falkson HC
    Cancer Chemother Rep; 1972 Oct; 56(5):671-7. PubMed ID: 4569061
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.
    Gutterman JU; Mavligit G; Gottlieb JA; Burgess MA; McBride CE; Einhorn L; Freireich EJ; Hersh EM
    N Engl J Med; 1974 Sep; 291(12):592-7. PubMed ID: 4851001
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide.
    Gottlieb JA; Baker LH; Quagliana JM; Luce JK; Whitecar JP; Sinkovics JG; Rivkin SE; Brownlee R; Frei E
    Cancer; 1972 Dec; 30(6):1632-8. PubMed ID: 4663966
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and imidazole carboxamide (NSC 45388) with vincristine (NSC 67574) in the palliation of disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer Res; 1972 Nov; 32(11):2432-4. PubMed ID: 5082592
    [No Abstract]   [Full Text] [Related]  

  • 16. 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of advanced acute lymphocytic leukemia in children.
    Finklestein JZ; Albo V; Ertel I; Karon M; Hammond D
    Cancer Chemother Rep; 1972 Aug; 56(4):523-6. PubMed ID: 4507686
    [No Abstract]   [Full Text] [Related]  

  • 17. Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
    Gams RA; Carpenter JT
    Cancer Chemother Rep; 1974; 58(5 Pt 1):753-4. PubMed ID: 4214608
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of antileukemic agents in mice inoculated with leukemia L1210 variants resistant to 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) or 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196).
    Kline I; Woodman RJ; Gang M; Venditti JM
    Cancer Chemother Rep; 1971 Feb; 55(1):9-28. PubMed ID: 5121657
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical evaluation of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide in malignant melanoma and other neoplasms: comparison of twice-weekly and daily administration schedules.
    Gottlieb JA; Serpick AA
    Oncology; 1971; 25(3):225-33. PubMed ID: 5153084
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of 4-carbethoxy-5(3,3-dimethyl-1-triazeno)-2-phenylimidazole (NSC-166721) and 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole (NSC-166722) as potential antitumor agents.
    Heyes J; Catherall EJ; Cockburn A
    Cancer Chemother Rep; 1973; 57(3):263-8. PubMed ID: 4751253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.